Role Of Cell And Gene Therapy Trials In Tackling Genetic Diseases Driver: Leading Transformation in the Cell And Gene Therapy Clinical Trial Services Market in 2025

What Are the Projected Growth and Market Size Trends for the Cell And Gene Therapy Clinical Trial Services Market?
The market size for clinical trial services related to cell and gene therapy has experienced quick expansion in the past few years. Forecasts predict growth from $3.79 billion in 2024 to $4.2 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.7%. Numerous factors have spurred growth in the historic era including a rise in chronic disease cases, a surge in demand for effective treatments for uncommon genetic disorders, more government investment in regenerative medicine research, a deeper understanding of molecular mechanisms contributing to various diseases, and a growing acknowledgment of personalized medicine potential.

Expectations are high that in the ensuing years, the market size for cell and gene therapy clinical trial services will undergo quick expansion. By 2029, the market value is projected to hit the $6.22 billion mark, reflecting a compound annual growth rate (CAGR) of 10.3%. The projected growth within the forecast period can be correlated with the escalating worldwide prevalence of genetic and auto-immune diseases, increased funding from public and private sectors directed towards gene therapy research, rising adoption of innovative technologies, and an increase in genetic defects. The forecast period will likely see predominant trends like the implementation of AI, the use of machine learning, the embrace of personalized medicine, technological developments, and gene therapies.

What Key Elements Are Boosting Growth in the Cell And Gene Therapy Clinical Trial Services Market?
An increase in genetic diseases is predicted to boost the expansion of the cell and gene therapy clinical trial services market in the future. Genetic diseases, which are disorders resulting from changes in an individual's DNA or genetic structure, are growing in prevalence due to various factors like widespread availability of genetic testing, the emergence of genetic mutations, and the widespread occurrence of inherited marriages. The cell and gene therapy clinical trial services are designed to counter this increasing prevalence of genetic diseases by promoting the innovation of new treatments, customizing therapies for each patient, speeding up the process of turning research into clinical practices, and enhancing the alternatives available to patients with genetic disorders. For example, in July 2022, the Cystic Fibrosis (CF) Foundation, a non-profit organization located in the U.S., reported a surge in cystic fibrosis patients. The disease impacted approximately 40,000 children and adults in the U.S. and a diagnosis was made for over 105,000 people worldwide in 2022. Consequently, the escalating prevalence of genetic diseases is stimulating the advancement of the cell and gene therapy clinical trial services market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15535&type=smp

Which Leading Companies Are Shaping the Growth of the Cell And Gene Therapy Clinical Trial Services Market?
Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.

What Are the Major Trends Shaping the Cell And Gene Therapy Clinical Trial Services Market?
Key players in the cell and gene therapy clinical trial services industry are directing their attention towards implementing customer relationship management system technology in advanced methods as they seek to enhance efficiency and gain a more significant market advantage. The cell and gene therapy clinical trial services use the customer relationship management system to facilitate and organize mutual interactions with medical trial participants, healthcare providers, and involved parties throughout the clinical trial procedure. An example of this, in April 2023, AmerisourceBergen Corporation, an American healthcare company, unveiled a platform called the Cell and Gene Therapy (CGT) Integration Hub. This platform aims to boost interconnection and facilitate processes along the cell and gene therapy treatment pathway. This particular platform is supported by AmerisourceBergen's CRM system designed to simplify the patient care process, offering doctors and patient services teams enhanced scrutiny across the therapy development and implementation stages. The CGT Integration Hub, fitted with expedited benefits investigation, actual-time status tracking, and proactive warnings, is intended to ease care coordination, face down obstacles, and enhance the whole patient and provider experience when delivering cell and gene therapies.

What Are the Key Segments of the Cell And Gene Therapy Clinical Trial Services Market?
The cell and gene therapy clinical trial services market covered in this report is segmented -

1) By Service: Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services
2) By Therapy Type: Gene Therapy, Cell Therapy, Gene Modified Cell Therapy
3) By Indication: Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications
4) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users

Subsegments:
1) By Clinical Trial Design And Planning: Protocol Development, Trial Feasibility Studies, Trial Design Consultation, Patient Recruitment And Enrollment Strategy, Risk-Based Monitoring Plans
2) By Supply And Logistic Services: Clinical Trial Supply Chain Management, Cold Chain Logistics, Packaging And Labeling Services, Transportation And Distribution Of Biological Samples, Customs And Import/Export Services
3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting, Regulatory Submission And Documentation, Compliance With GMP (Good Manufacturing Practices), Regulatory Pathway Consultation, Clinical Trial Applications (CTAs)
4) By Data Management And Biostatistics: Clinical Data Management (CDM), Statistical Analysis And Reporting, Clinical Data Monitoring, Data Integration And Validation, Electronic Data Capture (EDC) Solutions
5) By Site Management And Monitoring: Site Selection And Initiation, Clinical Monitoring And Site Visits, Patient Recruitment And Retention, Site Training And Support, Site Performance Monitoring
6) By Other Services: Patient Advocacy And Engagement, Real-World Evidence (RWE) Studies, Post-Trial Services, Medical Writing And Documentation, Clinical Trial Auditing And Inspection

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-clinical-trial-services-global-market-report

Which Region Dominates the Cell And Gene Therapy Clinical Trial Services Market?
North America was the largest region in the cell and gene therapy clinical trial services market in 2023. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Cell And Gene Therapy Clinical Trial Services Global Market Report?

- Market Size Analysis: Analyze the Cell And Gene Therapy Clinical Trial Services Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Cell And Gene Therapy Clinical Trial Services Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Cell And Gene Therapy Clinical Trial Services Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Cell And Gene Therapy Clinical Trial Services Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15535

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.